Siever L J, Uhde T W, Jimerson D C, Lake C R, Silberman E R, Post R M, Murphy D L
Am J Psychiatry. 1984 Jun;141(6):733-41. doi: 10.1176/ajp.141.6.733.
The authors measured plasma 3-methoxy-4-hydroxyphenylglycol (MHPG), plasma norepinephrine, blood pressure, and heart rate responses to the alpha 2-adrenergic agonist clonidine in 25 depressed patients and 25 normal control subjects. In the control subjects clonidine reduced plasma norepinephrine, blood pressure, and heart rate significantly more than placebo. In the depressed patients clonidine reduced blood pressure and the percent fall in plasma norepinephrine but not plasma MHPG or heart rate significantly more than placebo. The absolute and percent reductions in plasma MHPG and heart rate following clonidine were significantly less than in control subjects. These results raise the possibility that the sensitivity of the alpha 2-adrenergic receptors inhibitory to noradrenergic output may be reduced in depression.
作者测量了25名抑郁症患者和25名正常对照者对α2-肾上腺素能激动剂可乐定的血浆3-甲氧基-4-羟苯乙二醇(MHPG)、血浆去甲肾上腺素、血压和心率反应。在对照者中,可乐定降低血浆去甲肾上腺素、血压和心率的幅度显著大于安慰剂。在抑郁症患者中,可乐定降低血压以及血浆去甲肾上腺素下降的百分比,但降低血浆MHPG或心率的幅度并不显著大于安慰剂。可乐定给药后血浆MHPG和心率的绝对降低值和降低百分比显著低于对照者。这些结果提示,抑郁症患者中抑制去甲肾上腺素能输出的α2-肾上腺素能受体的敏感性可能降低。